2014 Opportunities in the Japanese Cancer Diagnostics Market is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Japanese cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.
Business Opportunities and Strategic Recommendations
Cancer Diagnostic Tests-Over 200 current and emerging assays including:
ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA, Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others.
Market Segmentation Analysis
Current and Emerging Products
Strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.
Contains 590 pages and 95 tables
SIMILAR MARKET STUDIES
Complete report $6,950. DataPack (test volumes, sales forecasts, supplier shares) $4,500. VPGMarketResearch’s new report is an analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the French automated microbiology market; reviews current and emerging assays; analyzes potential ...
July 2016 | $0 | View Details >>
2016 Global Microbial Limit Test Instrument Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Microbial Limit Test Instrument industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report ...
April 2016 | $2850 | View Details >>
This new 233-page report from Venture Planning Group provides analysis of the Italian immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
January 2014 | $1500 | View Details >>
This new 271-page report from VPGMarketResearch.com provides a comprehensive analysis in the US endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: ...
October 2015 | $1500 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research